Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02151825 · ClinicalTrials.gov registry record · NA

Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects

A NA study of Adiposity and Gut -Microbiota, sponsored by Texas State University, San Marcos.

Completed
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT02151825 is a NA study of Adiposity and Gut -Microbiota that has completed, run by Texas State University, San Marcos. The registered enrollment target is 54 participants, below the 96-participant average among 11 other Adiposity trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02151825, a NA study of Adiposity and Gut -Microbiota, has completed, sponsored by Texas State University, San Marcos.

COMPLETED
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effects of a synbiotic (ProSynbiotic) on the gut microbiota composition, body composition and adiposity-related genes and metabolic markers in healthy overweight adult subjects.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Synbiotic

Study Locations (1)

Texas

  • Texas State University - San Marcos

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2011-09
Est. Completion 2012-10
Phase NA

What the Registry Record Tells You About NCT02151825

The ClinicalTrials.gov registry entry for NCT02151825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 11 other Adiposity trials with a reported enrollment target (44% lower). The listed sponsor is Texas State University, San Marcos, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Adiposity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02151825 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02151825 about?

NCT02151825 is a clinical study titled "Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects". The purpose of this study is to investigate the effects of a synbiotic (ProSynbiotic) on the gut microbiota composition, body composition and adiposity-related genes and metabolic markers in healthy overweight adult subjects.

What is the current status of trial NCT02151825?

This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2011-09. Estimated completion is 2012-10.

What conditions does trial NCT02151825 study?

This clinical trial studies the following conditions: Adiposity, Gut -Microbiota.

What interventions are being tested in trial NCT02151825?

The interventions under investigation include: Placebo (OTHER), Synbiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02151825?

This trial is sponsored by Texas State University, San Marcos, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02151825 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adiposity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.